By Dr. med. Claudia Schmiemann
In 2013 the worldwide first 589nm yellow laser has been introduced by Dr. Michael Weber, Germany.
This closed a gap in low level laser therapy (LLLT) as it was the last missing prismatic color.
The yellow laser light stimulates the mitochondrial respiratory chain at complex III (cytochromes).
It is highly effective as a treatment of depression if it is combined with Hypericin (St. John´s Wort).
A broad range of studies shows that anti-depressive effects of Hypericin can be strengthened significantly
once the impact of Hypericin is enhanced by yellow laser.
Also, convincing results, we see with panic attacks and anxiety disorders by combining with Tryptophan.
Combined with Hypericin yellow laser is also applicable for the treatment of viral and chronic bacterial infections
via anti-microbial photodynamic therapy. In this context the clinical data for the treatment of advanced Lyme disease
and several viral infections (Herpes, Ebstein Barr, Human Cytomegalie Virus, etc.) is especially good.
There are studies that show that MS is influenced positively (sensomotoric abilities and fatigue syndrome).
…. To be continued…..
902-640-2100 Lunenburg, Nova Scotia
Comentarios